Japan approves AstraZeneca’s Calquence for adult patients with treatment-naïve CLL EP News Bureau Dec 29, 2022 Calquence was previously approved in Japan for the treatment of adults with relapsed or refractory Chronic Lymphocytic Leukaemia…
